ZNF583
gene geneOn this page
Also known as FLJ31030
Summary
ZNF583 (zinc finger protein 583, HGNC:26427) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 583 (Q96ND8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 147949 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_152478
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26427 |
| Approved symbol | ZNF583 |
| Name | zinc finger protein 583 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ31030 |
| Ensembl gene | ENSG00000198440 |
| Ensembl biotype | protein_coding |
| Entrez | 147949 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 12 protein_coding, 2 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000291598, ENST00000333201, ENST00000391778, ENST00000436972, ENST00000537943, ENST00000539211, ENST00000585612, ENST00000588635, ENST00000890730, ENST00000890731, ENST00000890732, ENST00000890733, ENST00000923221, ENST00000923222, ENST00000969490, ENST00000969491
RefSeq mRNA: 3 — MANE Select: NM_152478
NM_001159860, NM_001159861, NM_152478
CCDS: CCDS12943
Canonical transcript exons
ENST00000333201 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002203011 | 56404332 | 56404452 |
| ENSE00002321587 | 56422891 | 56427364 |
| ENSE00002487592 | 56414345 | 56414440 |
| ENSE00003499018 | 56413959 | 56414085 |
| ENSE00003653089 | 56407026 | 56407123 |
Expression profiles
Bgee: expression breadth ubiquitous, 169 present calls, max score 86.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.3606 / max 162.8225, expressed in 1309 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177718 | 3.3606 | 1309 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.67 | gold quality |
| cortical plate | UBERON:0005343 | 84.30 | gold quality |
| calcaneal tendon | UBERON:0003701 | 82.81 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.33 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.29 | gold quality |
| colonic epithelium | UBERON:0000397 | 78.51 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.12 | gold quality |
| right testis | UBERON:0004534 | 74.85 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.18 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.18 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.01 | gold quality |
| ventricular zone | UBERON:0003053 | 73.84 | gold quality |
| left testis | UBERON:0004533 | 73.73 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.38 | gold quality |
| granulocyte | CL:0000094 | 73.10 | gold quality |
| testis | UBERON:0000473 | 73.04 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 72.47 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 72.43 | gold quality |
| muscle of leg | UBERON:0001383 | 72.29 | gold quality |
| gastrocnemius | UBERON:0001388 | 72.29 | gold quality |
| cerebellar cortex | UBERON:0002129 | 72.06 | gold quality |
| popliteal artery | UBERON:0002250 | 71.95 | gold quality |
| tibial artery | UBERON:0007610 | 71.95 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.87 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 71.80 | gold quality |
| right coronary artery | UBERON:0001625 | 71.56 | gold quality |
| artery | UBERON:0001637 | 71.37 | gold quality |
| cerebellum | UBERON:0002037 | 71.34 | gold quality |
| left ovary | UBERON:0002119 | 71.29 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.07 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.83 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
66 targeting ZNF583, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp583 | ENSMUSG00000030443 |
| rattus_norvegicus | Zfp583 | ENSRNOG00000034184 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 583 — Q96ND8 (reviewed: Q96ND8)
Alternative names: Zinc finger protein L3-5
All UniProt accessions (3): Q96ND8, F5GZQ5, I3L0C4
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001153332, NP_001153333, NP_689691* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (19 total): zinc finger region 12, sequence conflict 2, chain 1, domain 1, region of interest 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96ND8-F1 | 71.72 | 0.45 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 62 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, TAATAAT_MIR126, GOZGIT_ESR1_TARGETS_DN, IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MIKKELSEN_MCV6_LCP_WITH_H3K4ME3, MIKKELSEN_MEF_LCP_WITH_H3K4ME3, MIKKELSEN_IPS_LCP_WITH_H3K4ME3, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR520D_5P, MIR524_5P, MIR548D_3P, MIR548H_3P_MIR548Z, MIR548BB_3P, MIR548AC
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
284 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF583 | TMEM247 | A6NEH6 | 512 |
| ZNF583 | WDR17 | Q8IZU2 | 507 |
| ZNF583 | BEND4 | Q6ZU67 | 484 |
| ZNF583 | UQCC6 | Q69YU5 | 478 |
| ZNF583 | CCDC81 | Q6ZN84 | 464 |
| ZNF583 | ST6GALNAC3 | Q8NDV1 | 420 |
| ZNF583 | BTG4 | Q9NY30 | 407 |
| ZNF583 | ALX3 | O95076 | 397 |
| ZNF583 | NWD2 | Q9ULI1 | 387 |
| ZNF583 | WDR87 | Q6ZQQ6 | 374 |
| ZNF583 | SMIM24 | O75264 | 369 |
| ZNF583 | TRAPPC6B | Q86SZ2 | 369 |
| ZNF583 | ST6GALNAC5 | Q9BVH7 | 368 |
| ZNF583 | NPTX1 | Q15818 | 348 |
| ZNF583 | A0A2R8Y6X2 | A0A2R8Y6X2 | 328 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF583 | psi-mi:“MI:0915”(physical association) | 0.490 | |
| APP | ZNF583 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): ZNF583 (Affinity Capture-MS), ZNF583 (Two-hybrid), ZNF583 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1033 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:56413955:TCAGG:T | acceptor_loss | 1.0000 |
| 19:56413956:CAG:C | acceptor_loss | 1.0000 |
| 19:56413957:AG:A | acceptor_gain | 1.0000 |
| 19:56413957:AGG:A | acceptor_loss | 1.0000 |
| 19:56413958:GG:G | acceptor_gain | 1.0000 |
| 19:56414046:A:T | donor_gain | 1.0000 |
| 19:56414083:TGGGT:T | donor_loss | 1.0000 |
| 19:56414084:GG:G | donor_gain | 1.0000 |
| 19:56414085:GG:G | donor_gain | 1.0000 |
| 19:56414086:G:GG | donor_gain | 1.0000 |
| 19:56414086:GT:G | donor_loss | 1.0000 |
| 19:56421522:T:G | donor_gain | 1.0000 |
| 19:56421522:T:TG | donor_gain | 1.0000 |
| 19:56421526:G:GG | donor_gain | 1.0000 |
| 19:56422889:A:AG | acceptor_gain | 1.0000 |
| 19:56422890:G:GG | acceptor_gain | 1.0000 |
| 19:56404427:G:GT | donor_gain | 0.9900 |
| 19:56404521:GTGT:G | donor_gain | 0.9900 |
| 19:56407024:A:AG | acceptor_gain | 0.9900 |
| 19:56407025:G:GG | acceptor_gain | 0.9900 |
| 19:56407025:GCTC:G | acceptor_gain | 0.9900 |
| 19:56413957:A:AG | acceptor_gain | 0.9900 |
| 19:56413958:G:GA | acceptor_gain | 0.9900 |
| 19:56413958:GGAT:G | acceptor_gain | 0.9900 |
| 19:56413958:GGATT:G | acceptor_gain | 0.9900 |
| 19:56414069:GAGC:G | donor_gain | 0.9900 |
| 19:56414072:C:G | donor_gain | 0.9900 |
| 19:56414082:TTGG:T | donor_gain | 0.9900 |
| 19:56422886:TTTAG:T | acceptor_loss | 0.9900 |
| 19:56422887:TTA:T | acceptor_loss | 0.9900 |
AlphaMissense
3807 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:56423487:T:C | F277L | 0.999 |
| 19:56423489:C:A | F277L | 0.999 |
| 19:56423489:C:G | F277L | 0.999 |
| 19:56423991:T:C | F445L | 0.999 |
| 19:56423993:T:A | F445L | 0.999 |
| 19:56423993:T:G | F445L | 0.999 |
| 19:56424159:T:C | F501L | 0.999 |
| 19:56424161:T:A | F501L | 0.999 |
| 19:56424161:T:G | F501L | 0.999 |
| 19:56423571:T:C | F305L | 0.998 |
| 19:56423573:C:A | F305L | 0.998 |
| 19:56423573:C:G | F305L | 0.998 |
| 19:56423823:T:C | F389L | 0.998 |
| 19:56423825:C:A | F389L | 0.998 |
| 19:56423825:C:G | F389L | 0.998 |
| 19:56423907:T:C | F417L | 0.998 |
| 19:56423909:C:A | F417L | 0.998 |
| 19:56423909:C:G | F417L | 0.998 |
| 19:56424075:T:C | F473L | 0.998 |
| 19:56424077:T:A | F473L | 0.998 |
| 19:56424077:T:G | F473L | 0.998 |
| 19:56423403:T:C | F249L | 0.997 |
| 19:56423405:C:A | F249L | 0.997 |
| 19:56423405:C:G | F249L | 0.997 |
| 19:56423655:T:C | F333L | 0.997 |
| 19:56423657:T:A | F333L | 0.997 |
| 19:56423657:T:G | F333L | 0.997 |
| 19:56423739:T:C | F361L | 0.997 |
| 19:56423741:T:A | F361L | 0.997 |
| 19:56423741:T:G | F361L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000269750 (19:56414551 CA>C), RS1000286757 (19:56421877 A>C), RS1000356289 (19:56402454 G>A), RS1000360040 (19:56422161 G>A), RS1000528512 (19:56403651 T>A,C), RS1000699172 (19:56408957 G>C), RS1000708727 (19:56408580 A>G), RS1000743015 (19:56406798 A>G), RS1000914086 (19:56416393 A>C), RS1000962978 (19:56403264 G>A), RS1001037726 (19:56424696 C>A,T), RS1001090248 (19:56424203 T>C), RS1001191892 (19:56421739 T>A), RS1001509660 (19:56422327 C>T), RS1001980143 (19:56422583 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| terbufos | decreases methylation | 1 |
| arsenite | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Fonofos | decreases methylation | 1 |
| Parathion | decreases methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.